KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05618730` - Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B	Phase 1
Not yet recruiting	`NCT05248139` - Safety and Effectiveness of Drop-free Small Incision Cataract Surgery	N/A
Terminated	`NCT01214174` - Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients	Phase 2
Completed	`NCT03332342` - Closed Eye Neutrophils in Dry Eye Disease	N/A
Completed	`NCT02128113` - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD	Phase 2
Completed	`NCT01808547` - Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects	Phase 3
Completed	`NCT04374656` - Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
Recruiting	`NCT05668455` - Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)	Phase 3
Completed	`NCT00645671` - Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery	Phase 3
Completed	`NCT00789971` - Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification	N/A
Completed	`NCT02786901` - LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery	Phase 3
Completed	`NCT00699153` - Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery	Phase 3
Completed	`NCT01576952` - Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects	Phase 3
Withdrawn	`NCT03408015` - Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease	Phase 4
Completed	`NCT03580473` - Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification	Phase 2
Completed	`NCT04812951` - Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery	Early Phase 1
Completed	`NCT03302273` - Corneal Epithelial Stem Cells and Dry Eye Disease	N/A
Completed	`NCT04690829` - Biomarkers in Ocular Inflammation and Uveitis
Withdrawn	`NCT01721694` - Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection	Phase 3
Completed	`NCT03521791` - Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.	Phase 4

NCT number	NCT03596723
Study type	Interventional
Source	Kala Pharmaceuticals, Inc.
Contact
Status	Terminated
Phase	Phase 3
Start date	July 3, 2018
Completion date	October 18, 2018

KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms